Hong Kong
· Delayed Price · Currency is HKD Shanghai Junshi Biosciences Statistics
Total Valuation
Shanghai Junshi Biosciences has a market cap or net worth of HKD 23.59 billion. The enterprise value is 22.93 billion.
| Market Cap | 23.59B |
| Enterprise Value | 22.93B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Shanghai Junshi Biosciences has 984.87 million shares outstanding. The number of shares has increased by 3.06% in one year.
| Shares Outstanding | 984.87M |
| Shares Change (YoY) | +3.06% |
| Shares Change (QoQ) | +1.84% |
| Owned by Insiders (%) | 19.99% |
| Owned by Institutions (%) | 18.00% |
| Float | 571.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.05 |
| PB Ratio | 1.51 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.05 |
| EV / Sales | 13.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -7.99 |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 38.90.
| Current Ratio | 2.11 |
| Quick Ratio | 1.73 |
| Debt / Equity | 38.90 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.96 |
| Interest Coverage | -53.89 |
Financial Efficiency
Return on equity (ROE) is -27.25% and return on invested capital (ROIC) is -12.86%.
| Return on Equity (ROE) | -27.25% |
| Return on Assets (ROA) | -10.94% |
| Return on Capital (ROIC) | -12.86% |
| Revenue Per Employee | 687,009 |
| Profits Per Employee | -819,441 |
| Employee Count | 2,568 |
| Asset Turnover | 0.14 |
| Inventory Turnover | 0.98 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.31% in the last 52 weeks. The beta is 0.35, so Shanghai Junshi Biosciences's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | -48.31% |
| 50-Day Moving Average | 11.95 |
| 200-Day Moving Average | 13.59 |
| Relative Strength Index (RSI) | 37.67 |
| Average Volume (20 Days) | 981,722 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shanghai Junshi Biosciences had revenue of HKD 1.74 billion and -2.07 billion in losses. Loss per share was -2.11.
| Revenue | 1.74B |
| Gross Profit | 1.10B |
| Operating Income | -2.14B |
| Pretax Income | -2.15B |
| Net Income | -2.07B |
| EBITDA | -1.85B |
| EBIT | -2.14B |
| Loss Per Share | -2.11 |
Balance Sheet
The company has 3.56 billion in cash and 2.76 billion in debt, giving a net cash position of 797.59 million or 0.81 per share.
| Cash & Cash Equivalents | 3.56B |
| Total Debt | 2.76B |
| Net Cash | 797.59M |
| Net Cash Per Share | 0.81 |
| Equity (Book Value) | 7.10B |
| Book Value Per Share | 7.07 |
| Working Capital | 2.72B |
Cash Flow
In the last 12 months, operating cash flow was -1.77 billion and capital expenditures -1.10 billion, giving a free cash flow of -2.87 billion.
| Operating Cash Flow | -1.77B |
| Capital Expenditures | -1.10B |
| Free Cash Flow | -2.87B |
| FCF Per Share | -2.91 |
Margins
Gross margin is 63.39%, with operating and profit margins of -123.07% and -119.28%.
| Gross Margin | 63.39% |
| Operating Margin | -123.07% |
| Pretax Margin | -123.48% |
| Profit Margin | -119.28% |
| EBITDA Margin | -106.51% |
| EBIT Margin | -123.07% |
| FCF Margin | -165.02% |
Dividends & Yields
Shanghai Junshi Biosciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.06% |
| Shareholder Yield | -3.06% |
| Earnings Yield | -19.70% |
| FCF Yield | -27.24% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |